Isaac Kinde: Finding cancer via altered genes
Baltimore biotech star aims to detect cancer mutations early
![Isaac Kinde headshot](https://i0.wp.com/www.sciencenews.org/wp-content/uploads/2015/09/100315_nobels_kinde-isaac.jpg?fit=860%2C460&ssl=1)
DETECTION Isaac Kinde, 31, is the chief scientific officer of PapGene, Inc. The company’s technologies can identify mutations commonly associated with cancer.
Courtesy of I. Kinde